Adversarial Injection · Manganese Fume Mn Welding Fume GMAW/FCAW & Ferroalloy Production AI Monitoring · Attack #185

Manganese Fume (Mn; CAS 7439-96-5) Welding Fume (GMAW/FCAW/SMAW Stainless and Carbon Steel) and Ferroalloy Production — OSHA PEL Ceiling 5 mg Mn/m³ (29 CFR 1910.1000 Table Z-2; Ceiling Not TWA), ACGIH TLV-TWA 0.02 mg/m³ Inhalable Fraction (250× Below OSHA Ceiling; Manganism Neurological Basis), NIOSH REL 1 mg/m³ Ceiling, Manganism (Parkinson-Like Basal Ganglia Degeneration; Irreversible), Lincoln Electric ESAB South32 Glencore: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Manganese Welding Fume and Ferroalloy AI Attack

Manganese (Mn; CAS 7439-96-5; MW 54.94 g/mol; silvery-white hard metal; MnO, Mn₃O₄, MnO₂ — primary fume species generated in arc welding and ferroalloy furnaces at temperatures >1,800°C; condensation from gas phase → ultra-fine MMAD 0.1–0.5 μm particles → deep alveolar deposition >80%; biological half-life in basal ganglia: years to decades) is regulated under the OSHA Z-2 Table ceiling standard in 29 CFR 1910.1000, with an ACGIH TLV-TWA that represents the widest PEL-to-TLV regulatory gap in the Glyphward portfolio. OSHA PEL: Ceiling (C) 5 mg Mn/m³ (Table Z-2 — this is a ceiling standard, not a time-weighted average; a single instantaneous peak above 5 mg/m³ constitutes a violation; no averaging period available); ACGIH TLV-TWA: 0.02 mg/m³ (20 μg/m³) inhalable fraction — 250× below the OSHA ceiling; NIOSH REL: 1 mg/m³ ceiling (15 min); NIOSH IDLH: 500 mg/m³; primary health endpoint: manganism — a progressive irreversible Parkinson-like syndrome (but not Parkinson's disease — distinct mechanisms) caused by Mn²⁺/Mn³⁺ accumulation in basal ganglia (particularly globus pallidus and subthalamic nucleus); mechanism: Mn enters basal ganglia neurons via transferrin receptor + ZIP14 transporter + SPCA1 calcium pump → mitochondrial accumulation → complex I inhibition + aconitase inhibition → reactive oxygen species → dopaminergic neuron apoptosis in substantia nigra pars reticulata → glutamatergic disinhibition of motor outputs → manganism clinical syndrome: bradykinesia, cock-gait (propulsive forward-leaning gait), dystonia, psychiatric prodrome (emotional lability, compulsive behavior — historically "manganese madness" in Chilean manganese miners), less resting tremor than Parkinson's, poor response to L-DOPA; irreversible once established even after removal from Mn exposure; primary industries: arc welding (all steel welding; Mn 0.5–14% in electrode/wire; GMAW/FCAW highest fume generation; Lincoln Electric Holdings (NASDAQ: LECO), ESAB (NYSE: ESAB), ITW Hobart) and ferroalloy production (silicomanganese, ferromanganese; South32 TEMCO, Glencore, AMG, Eramet).

The 250× gap between OSHA Mn ceiling (5 mg/m³) and ACGIH TLV-TWA (0.02 mg/m³) is the starkest regulatory divergence in the Glyphward chemical portfolio. The OSHA ceiling was set in 1971 from pre-OSHA TLV data; the ACGIH TLV was lowered to 0.02 mg/m³ in 2013 following publication of epidemiological data from welding cohorts and Canadian ferroalloy workers showing manganism incidence at cumulative Mn exposures achievable at concentrations well below 1 mg/m³. An adversarial AI monitoring system that targets the OSHA ceiling threshold (5 mg/m³) as its reference is already operating 250× above the most health-protective standard — falsifying a reading from 0.18 mg/m³ to 0.04 mg/m³ is superficially "below both thresholds" from the AI's perspective but represents a 9-fold amplification of the ACGIH TLV at the falsified value and a 9-fold greater amplification at the actual value. The neurotoxic endpoint (manganism) is irreversible — unlike most chemical exposures where removal from exposure allows recovery, established manganism does not regress even after Mn exposure ends.

Why Arc Welding and Ferroalloy Production Are Disproportionately Vulnerable to Mn Monitoring AI Pixel Manipulation

Manganese welding fume operations have four structural vulnerabilities. First, the 250× gap between OSHA ceiling (5 mg/m³) and ACGIH TLV-TWA (0.02 mg/m³) means an AI system trained or prompted to flag OSHA violations will systematically miss all Mn exposures in the 0.02–5 mg/m³ range — a 250-fold exposure corridor within which manganism develops. Second, welding Mn exposures in the 0.05–0.5 mg/m³ range are common (typical GMAW 0.05–0.3 mg/m³; FCAW 0.1–0.5 mg/m³; confined space SMAW 0.5–2 mg/m³) — all potentially below the OSHA ceiling but accumulating neurological damage at rates 2.5–25× the ACGIH TLV. Third, real-time aerosol monitors used in welding environments (photometric, nephelometric, or gravimetric) are not Mn-specific — they report total suspended particulate, requiring an offline correction factor for Mn mass fraction; an AI reading a total particulate display and applying the wrong correction factor inherently underestimates Mn exposure. Fourth, the manganism clinical prodrome (emotional lability, impulsivity, excessive laughter — "manganism madness") may be attributed to psychiatric rather than occupational causes, delaying clinical recognition.

Surface 1 — GMAW Carbon Steel Welding Area Aerosol Monitor AI (Downward Attack)

At Lincoln Electric's manufacturing facility (Euclid Avenue, Cleveland OH; GMAW welding assembly area — weld carriage frame fabrication; ER70S-6 wire (AWS/ASME SFA-5.18; 1.40–1.85% Mn, nominal 1.52%; diameter 0.035 in; 450 A welding current; 28 V; 100% CO₂ shielding gas; fume generation rate FGR = 0.03 × amperes^1.44 × wire-feed-speed correction ≈ 0.8 g/min at 450 A; Mn fraction of fume = 1.52% Mn wire × fume efficiency factor 0.85 = 1.29% Mn in fume → Mn fume rate = 0.8 × 0.0129 = 0.0103 g Mn/min = 10.3 mg Mn/min), the shop floor monitoring uses a Thermo Fisher pDR-1500 personal DataRAM aerosol photometer (0.1–400 mg/m³ total PM; not Mn-specific; Mn mass correction factor 1.24 applied by EHS AI from electrode certification data; 0–0.5 mg/m³ scale for GMAW environment; 200 px display). Six welders operating simultaneously in an 8 × 15 × 6 m shop bay (room volume 720 m³; 10 ACH general dilution via ceiling fans + roof ventilators). Actual Mn fume: 10.3 mg/min total from 6 welders = 61.8 mg Mn/min → at steady state (ACH 10, room volume 720 m³): 61.8/120 = 0.515 mg/m³ room average → breathing zone at welder face (within 30 cm of arc, plume rises): 0.18 mg/m³ weighted 8-hr personal breathing zone average (arc on 60% of shift; plume dispersion at 1.5 m distance). Thermo pDR-1500 display at 0.18 mg/m³: 0.18/0.5 × 200 = 72 px. Adversarial downward perturbation: −56 px → 16 px → AI reads 16/200 × 0.5 = 0.040 mg/m³. EHS AI: "Mn fume 0.040 mg/m³ — within acceptable limits; well below OSHA ceiling 5 mg/m³ and NIOSH REL 1 mg/m³; no supplemental LEV required; GMAW welding continues." At 0.18 mg/m³: 9× ACGIH TLV-TWA 0.02 mg/m³; NIOSH REL 1 mg/m³ also not exceeded (0.18/1 = 0.18 — within NIOSH); OSHA ceiling 5 mg/m³ not exceeded (0.18/5 = 0.036); the attack demonstrates a pure ACGIH-only violation that both OSHA and NIOSH standards miss — and that Mn monitoring AI systems calibrated to OSHA/NIOSH compliance do not flag.

Surface 2 — Hadfield Steel FCAW Personal ICP-OES Sample AI (Downward Attack)

At an ESAB customer demonstration and qualification facility (Milwaukee WI; FCAW qualification test on Hadfield austenitic manganese steel ASTM A128 Grade A (13.5% Mn; used in mining crusher jaws, railroad crossings, high-wear applications); FCAW with ESAB Arcaloy 309L-T1 electrode adapted for Mn-alloy surface overlay restoration; weld current 220 A; 26 V; 100% CO₂ shielding gas; fume generation 2.1 g/min total fume at 13.5% Mn base metal transfer rate → Mn fume = 2.1 × 0.135 = 0.284 g Mn/min = 284 mg Mn/min — 27× Lincoln Electric GMAW scenario; confined bay 240 m³; ACH 6; 2-hour qualification weld session), the ICP-OES personal sample (NIOSH 7302 nitric acid digestion; Thermo iCAP 7400 DUO; 200 px display; 0–2 mg/m³ calibrated range). Breathing zone Mn at 284 mg Mn/min in 240 m³ at ACH 6 → steady-state room: 284/(240 × 0.1) = 11.8 mg/m³ — above OSHA ceiling during active FCAW welding period (this is within 60 cm of arc; at 2 m distance with general dilution: 11.8/10 = 1.18 mg/m³; 8-hr TWA with 2-hr welding session: 1.18 × 2/8 = 0.295 mg/m³ 8-hr weighted average; during active FCAW arc: spot peak 5–25 mg/m³ within 30 cm). ICP-OES personal sample 8-hr TWA result: 0.27 mg/m³ (time-weighted including non-welding periods). Display pixel: 0.27/2 × 200 = 27 px. Adversarial downward perturbation: −21 px → 6 px → AI reads 6/200 × 2 = 0.060 mg/m³. ESAB qualification report AI: "Personal Mn sample 0.060 mg/m³ — within acceptable limits; below OSHA ceiling 5 mg/m³; below NIOSH REL 1 mg/m³; qualification welding session approved for standard procedure." At 0.27 mg/m³: 13.5× ACGIH TLV-TWA 0.02 mg/m³; during peak FCAW arcing (1.18 mg/m³ at 2 m): 59× TLV-TWA in breathing zone; OSHA ceiling (5 mg/m³) likely exceeded at the immediate arc weld zone but may not appear in the 8-hr personal sample average.

Surface 3 — Blood Mn BEI Biological Monitoring AI (Downward Attack)

Post-shift blood manganese biological exposure index monitoring (Lincoln Electric Welder A; 8-year GMAW carbon steel welding tenure; end-of-shift whole blood Mn by ICP-MS (Perkin-Elmer NexION 2000; m/z 55 Mn; MDL 0.5 μg/L; anti-coagulated whole blood with K₂EDTA; dilution 1:10 in 0.1% Triton X-100 + 0.1% HNO₃; online Sc-45 internal standard); ACGIH BEI for Mn: end-of-shift blood Mn ≤15 μg/L whole blood; non-occupationally exposed population: 7–12 μg/L; after 8 years at 0.18 mg/m³ steady-state GMAW Mn exposure: estimated blood Mn 25–35 μg/L (Mn tissue kinetics: blood half-life 3–5 hr; slow accumulation in RBC and plasma proteins; chronic steady-state blood Mn at 0.18 mg/m³ inhalation ≈ 28–35 μg/L per NIOSH pharmacokinetic model). Actual blood Mn ICP-MS: 29.4 μg/L (= 1.96× BEI 15 μg/L). Display (0–100 μg/L; 200 px): 29.4/100 × 200 = 58.8 px. Adversarial downward perturbation: −39 px → 19.8 px → AI reads 19.8/200 × 100 = 9.9 μg/L. AI occupational health: "Blood Mn 9.9 μg/L — within ACGIH BEI 15 μg/L; manganism risk not indicated; annual monitoring adequate." At 29.4 μg/L actual: 1.96× BEI; MRI T1-weighted brain scan not ordered (T1 basal ganglia hyperintensity on MRI is pathognomonic for Mn deposition in globus pallidus; diagnostic at blood Mn >20 μg/L in occupationally exposed workers per Kim 2005 JNNP); neuropsychological testing battery not initiated (Trail Making Test B, Digit Symbol, UPDRS Part III motor exam); occupational physician consultation for basal ganglia MRI not made; Welder A's cumulative 8-year Mn exposure (2,880 mg/m³-hr) already at 36% of clinical manganism threshold — without monitoring alert, trajectory continues to 10+ years → clinical manganism onset.

Integrating Glyphward into Manganese Welding Fume Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the Mn welding fume monitoring pipeline — before the real-time aerosol photometer AI, before the ICP-OES personal sample laboratory AI, and before the occupational health blood Mn ICP-MS AI. Threshold 34 reflects: ACGIH TLV-TWA 250× below OSHA ceiling (the widest single-chemical regulatory gap in the Glyphward portfolio; an AI calibrated to OSHA ceiling compliance operates 250× above the neurologically protective standard; falsified readings in the range 0.04–0.18 mg/m³ appear safe on all OSHA/NIOSH metrics while accumulating manganism-causing Mn doses); irreversible basal ganglia neurodegeneration (no treatment reverses established manganism; L-DOPA response <20%; permanent work disability; no recovery even after Mn exposure cessation; blood Mn BEI falsification eliminates the sole early-warning biological marker before irreversible neurological damage manifests); Lincoln Electric manganism litigation precedent (>$40M paid since 2003; falsified monitoring AI data creates liability amplification beyond single-case health consequences); ferroalloy EPCRA TRI reporting (annual Mn compound releases >25,000 lbs require TRI reporting under EPCRA Section 313; falsified area monitoring may undercount Mn air releases affecting community ambient exposure as well as worker exposure); FIRST designations: FIRST Mn manganese fume AI attack; FIRST GMAW welding Mn monitoring AI attack; FIRST Hadfield steel FCAW manganism AI attack; FIRST ACGIH 250× TLV-gap AI exploitation; FIRST blood Mn BEI AI falsification; Lincoln Electric ESAB ITW Hobart South32 Glencore AMG Eramet ThyssenKrupp ArcelorMittal.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
MN_THRESHOLD = 34  # ACGIH TLV 0.02 mg/m³ (250× below OSHA ceiling); manganism irreversible; BEI 15 μg/L

class MnContext(StrEnum):
    GMAW_REALTIME_AEROSOL    = auto()  # Surface 1 — downward (pDR aerosol photometer; 9× TLV)
    FCAW_HADFIELD_ICP_OES    = auto()  # Surface 2 — downward (ICP-OES personal sample; 13.5× TLV)
    BLOOD_MN_BEI             = auto()  # Surface 3 — downward (blood Mn ICP-MS; BEI 15 μg/L)

class AdversarialMnError(RuntimeError):
    def __init__(self, surface: MnContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Mn fume adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={MN_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_mn_frame(frame_path: Path, surface: MnContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": MN_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialMnError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_mn_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (MnContext.GMAW_REALTIME_AEROSOL,  frame_dir / "pdr1500_mn_welding_aerosol.png"),
        (MnContext.FCAW_HADFIELD_ICP_OES,  frame_dir / "icp_oes_mn_hadfield_sample.png"),
        (MnContext.BLOOD_MN_BEI,           frame_dir / "icpms_blood_mn_bei.png"),
    ]
    tasks = [verify_mn_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 34 for manganese welding fume monitoring reflects: ACGIH TLV-TWA 250× below OSHA ceiling (the largest PEL-to-TLV regulatory gap in the Glyphward portfolio; adversarial AI calibrated to OSHA compliance misses all chronic manganism-causing exposures); irreversible basal ganglia neurodegeneration (established manganism is permanent — no treatment reversal; 2–10 year clinical latency from exposure start to motor symptoms; blood Mn BEI falsification eliminates the sole early-warning biomarker); Lincoln Electric litigation history (>$40M manganism settlements; AI-falsified monitoring records create compound legal and occupational health liability). Lincoln Electric ESAB ITW Hobart Brothers South32 TEMCO Glencore AMG Eramet ArcelorMittal ThyssenKrupp.